Sector revisions Asahi Kasei Corporation

Equities

Market Closed - Japan Exchange Other stock markets 06:30:00 22/01/2026 GMT			5-day change	1st Jan Change
1,508.00 ^JPY	+0.97%		+1.00%	+8.57%

01-08	Zoll Strengthens Growth Trajectory for Asahi Kasei's Healthcare Sector with U.S. Launch of the Next-Generation Lifevest®? Wcd	CI
01-06	Tranche Update on Asahi Kasei Corporation's Equity Buyback Plan announced on November 5, 2025.	CI

Sector:

Location:

X axis:

Main competitors

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	1m. Revenue rev.	4m. EPS revision	4m. Revenue rev.	1y. EPS revision	1y. Revenue rev.	Visibility	Nbr of analysts
	ASAHI KASEI CORPORATION							12
	SHIN-ETSU CHEMICAL CO., LTD.							17
	BASF SE							21
	PIDILITE INDUSTRIES LIMITED							20
	SRF LIMITED							30
	MITSUBISHI CHEMICAL GROUP CORPORATION							11
	SYENSQO SA/NV							18
	BRENNTAG SE							15
	KUALA LUMPUR KEPONG							16
	TOSOH CORPORATION							9
	SUMITOMO CHEMICAL COMPANY, LIMITED							11
	NISSAN CHEMICAL CORPORATION							9
	SASOL LIMITED							9
	KEMIRA OYJ							6
	HAWKINS, INC.							3
	SOLVAY SA							16
	SAHARA INTERNATIONAL PETROCHEMICAL COMPANY							9
	ASHLAND INC.							10
	HUBEI YIHUA CHEMICAL INDUSTRY CO., LTD.							3
	Average							13
	Weighted average by Cap.							17